In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Symmetry Medical nets $123.1mm with IPO

Executive Summary

Symmetry Medical (orthopedic tools, instruments, and implants) netted $123.1mm (including the overallotment) through its initial public offering of 9.2mm shares priced at $15 each. The company, which filed for the IPO in May, had been majority-owned by private equity firm Olympus Partners since 2000.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register